Nagasawa, T.; Shoji, T.; Takatori, E.; Kaido, Y.; Kagabu, M.; Shimizu, D.; Shigeto, T.; Baba, T.; Sugiyama, T.; Yokoyama, Y.
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study). Cancers 2023, 15, 5201.
https://doi.org/10.3390/cancers15215201
AMA Style
Nagasawa T, Shoji T, Takatori E, Kaido Y, Kagabu M, Shimizu D, Shigeto T, Baba T, Sugiyama T, Yokoyama Y.
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study). Cancers. 2023; 15(21):5201.
https://doi.org/10.3390/cancers15215201
Chicago/Turabian Style
Nagasawa, Takayuki, Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, Masahiro Kagabu, Dai Shimizu, Tatsuhiko Shigeto, Tsukasa Baba, Toru Sugiyama, and Yoshihito Yokoyama.
2023. "A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)" Cancers 15, no. 21: 5201.
https://doi.org/10.3390/cancers15215201
APA Style
Nagasawa, T., Shoji, T., Takatori, E., Kaido, Y., Kagabu, M., Shimizu, D., Shigeto, T., Baba, T., Sugiyama, T., & Yokoyama, Y.
(2023). A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study). Cancers, 15(21), 5201.
https://doi.org/10.3390/cancers15215201